Categories
Antivaccine nonsense Bioethics Medicine

To unblind or not to unblind COVID-19 vaccine trials?

Antivaccine alternative health tycoon Joe Mercola claims that the unblinding of participants in the clinical trials of Moderna and Pfizer COVID-19 vaccines was intended to “blow up the trials” and undermine the science, making it impossible ever to identify long term adverse events. What he’s really doing is deceptively oversimplifying complex ethical and scientific issues surrounding these trials in the middle of a deadly pandemic, all in the service of his grift.

Categories
Bad science Bioethics Clinical trials Medicine Pseudoscience Quackery

Duke University’s stem cell program for autism: The dark(er) side of quackademic medicine

Despite a lack of evidence Duke University is all-in on stem cells for autism, thanks to a billionaire benefactor and a Panama stem cell clinic. This is the dark(er) side of quackademic medicine.

Categories
Antivaccine nonsense Bad science Bioethics Medicine Pseudoscience

False analogies and pseudoscience as “moral arguments” against the use of fetal cell lines to manufacture vaccines

Antivaxers frequently object to the use of fetal cell lines to manufacture vaccines on “moral” grounds. Über-quack Joe Mercola lays down some astonishingly bad moral arguments based on pseudoscience.

Categories
Bioethics Cancer Medicine Pseudoscience Quackery

Kylee Dixon: Oregon intervenes to treat her cancer

Kylee Dixon is a 13-year-old girl with undifferentiated embryonal sarcoma of the liver whose mother stopped chemotherapy and has been treating her with CBD oil. The State of Oregon intervened to see that Kylee undergoes appropriate surgery. Where do “parental rights” end and the child’s rights begin?

Categories
Bad science Bioethics Clinical trials

Pay-to-play clinical trials: The HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) weighs in

The ethics of pay-to-play clinical trials are a minefield. Last week the HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) stepped into that minefield. Are “pay-to-play” clinical trials ever ethically acceptable?